A detailed history of Morgan Stanley transactions in Surmodics Inc stock. As of the latest transaction made, Morgan Stanley holds 853,915 shares of SRDX stock, worth $35.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
853,915
Previous 1,241,793 31.24%
Holding current value
$35.9 Million
Previous $45.1 Million 44.5%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$27.44 - $35.56 $10.6 Million - $13.8 Million
-387,878 Reduced 31.24%
853,915 $25.1 Million
Q4 2023

Feb 13, 2024

BUY
$28.47 - $38.49 $31.9 Million - $43.1 Million
1,118,919 Added 910.62%
1,241,793 $45.1 Million
Q3 2023

Nov 15, 2023

BUY
$28.28 - $38.36 $1.76 Million - $2.39 Million
62,310 Added 102.88%
122,874 $3.94 Million
Q2 2023

Aug 14, 2023

SELL
$17.67 - $31.31 $79,020 - $140,018
-4,472 Reduced 6.88%
60,564 $1.9 Million
Q1 2023

May 15, 2023

SELL
$17.13 - $38.52 $337,854 - $759,729
-19,723 Reduced 23.27%
65,036 $1.48 Million
Q4 2022

Feb 14, 2023

SELL
$29.44 - $37.31 $30,588 - $38,765
-1,039 Reduced 1.21%
84,759 $2.89 Million
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $739,659 - $998,181
-25,647 Reduced 23.01%
85,798 $2.61 Million
Q2 2022

Oct 27, 2022

BUY
$33.25 - $45.11 $1.95 Million - $2.64 Million
58,556 Added 110.71%
111,445 $4.15 Million
Q2 2022

Aug 15, 2022

BUY
$33.25 - $45.11 $1.95 Million - $2.64 Million
58,556 Added 110.71%
111,445 $4.15 Million
Q1 2022

Oct 27, 2022

SELL
$40.68 - $49.72 $2.38 Million - $2.91 Million
-58,556 Reduced 52.54%
52,889 $2.4 Million
Q1 2022

May 13, 2022

SELL
$40.68 - $49.72 $49,182 - $60,111
-1,209 Reduced 2.23%
52,889 $2.4 Million
Q4 2021

Feb 14, 2022

BUY
$43.21 - $57.6 $120,858 - $161,107
2,797 Added 5.45%
54,098 $2.6 Million
Q3 2021

Nov 15, 2021

BUY
$52.8 - $60.32 $2.71 Million - $3.09 Million
51,301 New
51,301 $2.85 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $589M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.